doi: 10.1016/j.neuint.2019.04.010 15
WEGOVY tablets are indicated in combination with a reduced calorie diet and increased physical activity: To reduce the risk of major adverse CV events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight
Instead, slowly tapering off the medication may be more effective, especially if paired with guidance from a healthcare provider and lifestyle changes to maintain a healthy weight (which well detail in the next section)
If you are exploring compounded options, understanding the specific offerings from pharmacies like Empower Pharmacy , Olympia Pharmacy , or Belmar Pharmacy provides concrete comparison points
In clinical trials, tirzepatide 15 mg produced roughly twice the weight loss of semaglutide 1 mg, and the SURMOUNT-5 trial directly compared tirzepatide to semaglutide 2.4 mg for obesity, showing tirzepatide superiority